Financial Reports

ACGT’s complete 990 form is available for your review and information.

CONDENSED STATEMENTS OF ACTIVITIES 2015 2014
Support and revenue:
  Contributions  $960,174  $785,961
  Contributions for administrative expenses (specially designated)  364,150  279,100
  Contributed services  357,585  265,789
  Interest and dividend income  102,399  87,795
  Realized and unrealized gains on investments, net  160,067  216,559
  TOTAL SUPPORT AND REVENUE 1,944,375 1,635,204
Expenses:
  Program services:
     Research grants and awards  1,739,756  794,126
  Management and general  225,863  188,233
  Fundraising  103,799  56,246
  TOTAL EXPENSES 2,069,418 1,038,605
 (Decrease) increase in total net assets  (125,043)  596,599
  Total net assets at beginning of year  3,982,702  3,386,103
TOTAL NET ASSETS AT END OF YEAR $3,857,659 $3,982,702

 

CONDENSED STATEMENTS OF FINANCIAL POSITION 2015 2014
Assets:
   Cash and cash equivalents  $646,150  $471,784
   Contributions receivable, net  – 25,000
   Investments, at fair value  4,361,748  4,227,234
   Accounts receivable and prepaid expenses  24,055  8,430
  TOTAL ASSETS $5,031,953 $4,732,448
Liabilities and net assets:
  Liabilities
     Grants payable  $1,139,253  $728,762
     Accounts payable and accrued expenses  35,041  20,984
  TOTAL LIABILITIES 1,174,294 749,746
  TOTAL NET ASSETS 3,857,659 3,982,702
TOTAL LIABILITIES AND NET ASSETS $5,031,953 $4,732,448

Alliance for Cancer Gene Therapy, Inc.’s complete financial statements are available upon request.